Significant Ownership of Aberdeen Group plc

Signature - Title
Jenny Clarke - Major Shareholding Reporting Analyst
Location
Edinburgh, United Kingdom
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Aberdeen Group plc.

Notify me when Aberdeen Group plc files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Aberdeen Group plc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IMUX IMMUNIC, INC common stock 8.6% $6.84M 8.24M Aberdeen Group plc Jun 30, 2025
SERA SERA PROGNOSTICS, INC. Class A Common Stock $0.0001 par value per share 6.07% $6.33M 2.23M Aberdeen Group plc Jun 30, 2025
NSPR InspireMD, Inc. Common Stock, $0.0001 par value per share 5.95% $5.98M 2.48M Aberdeen Group plc Oct 1, 2025
QURE uniQure N.V. Ordinary Shares, par value(euro)0.05 per share 4.77% $172M $11M 2.94M +6.87% Aberdeen Group plc Sep 30, 2025
CDXS CODEXIS, INC. Common Stock, par value $0.0001 per share 4.53% $9.98M -$266K 4.09M -2.59% Aberdeen Group plc Oct 1, 2025

Schedules 13D/G Reported by Aberdeen Group plc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.